ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 168 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $508,355 | -35.1% | 102,285 | -17.8% | 0.00% | -42.9% |
Q4 2022 | $783,105 | -72.5% | 124,500 | -52.8% | 0.01% | -70.8% |
Q3 2022 | $2,851,000 | +111.2% | 263,891 | +122.9% | 0.02% | +84.6% |
Q2 2022 | $1,350,000 | +84.4% | 118,400 | +47.3% | 0.01% | +85.7% |
Q1 2022 | $732,000 | -29.6% | 80,400 | +98.5% | 0.01% | -36.4% |
Q3 2021 | $1,040,000 | -61.8% | 40,500 | -61.2% | 0.01% | -62.1% |
Q2 2021 | $2,719,000 | +910.8% | 104,279 | +942.8% | 0.03% | +190.0% |
Q4 2018 | $269,000 | – | 10,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
Navalign, LLC | 75,365 | $238,907 | 0.09% |